已收录 268921 条政策
 政策提纲
  • 暂无提纲
NB‐506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA
[摘要]

A novel competition dialysis method was used to study the structural selectivity of the nucleic acid binding of NB-506, a promising indolocarbazole anticancer agent. A pronounced preference for NB-506 binding to the DNA triplex poly [dA]:(poly[dT])2 was observed among potential binding to 12 different nucleic acid structures and sequences. Structures included in the assay ranged from single-stranded DNA, through a variety of right-handed DNA duplexes, to multistranded triplex and tetraplex forms. RNA and left-handed Z DNA were also included in the assay. The preferential binding to triplex was confirmed by UV melting experiments. The novel and unexpected structural selectivity shown by NB-506 may arise from a complementary shape between its extended aromatic ring system and the planar triplex stack.

[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生物化学/生物物理
[关键词] DNA;RNA;Intercalation;Dialysis;Anticancer drug;Triplex DNA [时效性] 
   浏览次数:15      统一登录查看全文      激活码登录查看全文